Magnesium Sulfate in Water for Injection — Class III drug recall D-1390-2012
Terminated recall by Hospira, Inc., reported 2012-06-27, distributed nationwide. Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.
| Recall number | D-1390-2012 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira, Inc., Lake Forest, IL, United States |
| Recall initiated | 2012-04-05 |
| Classified | 2012-06-20 |
| Reported by FDA | 2012-06-27 |
| Terminated | 2013-08-08 |
| Distributed | Nationwide (US) |
| Quantity | 164,568 containers |
| Reason classes | potency |
| NDC | 00409-2050, 00409-2050-01, 00409-2050-20, 00409-3164, 00409-3164-01, 00409-3164-12, 00409-4121, 00409-4121-01, 00409-4121-24, 00409-5239, 00409-5239-01, 00409-5239-24, 00409-6729, 00409-6729-11, 00409-6729-23, 00409-6729-24, 00409-6729-41 |
| Expiration dates | 2012-10-01 |
Product
Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-6729-24.
Reason for recall
Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1390-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.